| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.8M | +208.7% |
| Cost of Revenue | $536K | +373.6% |
| Gross Profit | $1.3M | +170.2% |
| R&D Expense | $26K | — |
| SG&A Expense | $1.1M | +62.3% |
| Operating Income | $87K | +134.6% |
| Income Tax | $0 | — |
| Net Income | $87K | +134.6% |
| EPS (Basic) | $0.00 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $663K | +3343.8% |
| Accounts Receivable | $100K | +175.1% |
| Inventory | $58K | +54.7% |
| Current Assets | $848K | +807.8% |
| Total Assets | $874K | +835.7% |
| Total Liabilities | $39K | -61.5% |
| Stockholders' Equity | $835K | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $23K | +107.5% |
| Investing Cash Flow | -$26K | — |
| Financing Cash Flow | $646K | +104.8% |
| +100.0% |
| EPS (Diluted) | $0.00 | +100.0% |